Daclatasvir-natdac (60 mg Tablets.)

NATCO PHARMA LIMITED (INDIA)

“Daclatasvir” is the Drug / Molecule content in “Natdac”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV).It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

Category:

Indication

Natdac is used for treatment of patients with chronic Hepatitis C .

Note

Precaution

  • Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
  • Natdac should not be used during pregnancy or in women of childbearing potential not using contraception.

Related products